Zhejiang Jutai Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG JUTAI PHARM, and what generic and branded alternatives to ZHEJIANG JUTAI PHARM drugs are available?
ZHEJIANG JUTAI PHARM has three approved drugs.
Summary for Zhejiang Jutai Pharm
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Zhejiang Jutai Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Jutai Pharm | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 214110-002 | Jul 26, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zhejiang Jutai Pharm | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 214110-003 | Jul 26, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zhejiang Jutai Pharm | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211200-002 | Apr 29, 2020 | AB3 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
